DRUGSRUS LIMITED — Doxycycline Importer Profile
Pharmaceutical Importer · #15 buyer for Doxycycline · $765.4K import value · 41 shipments · UNITED KINGDOM · DGFT Verified
DRUGSRUS LIMITED is the #15 importer of Doxycycline from India with $765.4K in import value and 41 verified shipments. DRUGSRUS LIMITED holds a 0.7% market share in Doxycycline imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 37 formulations shipped to 1 country.
DRUGSRUS LIMITED — Doxycycline Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Doxycycline to DRUGSRUS LIMITED?
Verified from 41 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PROSFORA TECHNOLOGIES PRIVATE LIMITED | $765.4K | 41 | 100.0% |
DRUGSRUS LIMITED sources Doxycycline from 1 verified Indian supplier based on 41 customs records. The primary supplier is PROSFORA TECHNOLOGIES PRIVATE LIMITED accounting for 100.0% of imports.
How Does DRUGSRUS LIMITED Compare to Nearest Doxycycline Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $1.0M | 20 | $50.0K |
| 7 | MYLAN INSTITUTIONAL INC | UNITED STATES | $900.0K | 18 | $50.0K |
| 15 | DRUGSRUS LIMITED ★ | UNITED KINGDOM | $851.9K | 41 | $20.8K |
| 10 | CARDINAL THIRD PARTY LOGISTICS | UNITED STATES | $800.0K | 16 | $50.0K |
| 5 | AMNEAL PHARMACEUTICALS, LLC (KY) | UNITED STATES | $700.0K | 14 | $50.0K |
DRUGSRUS LIMITED ranks #15 among 1,051 Doxycycline importers from India. Average shipment value of $20.8K compared to the market average of $22.5K. The closest competitors by value are MYLAN INSTITUTIONAL INC 2898 and MYLAN INSTITUTIONAL INC.
Where Does DRUGSRUS LIMITED Import Doxycycline To?
Destination countries from 41 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $765.4K | 41 | 100.0% |
DRUGSRUS LIMITED imports Doxycycline to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $765.4K.
What Doxycycline Formulations Does DRUGSRUS LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| DOXYCYCLINE 100MG CAPSULES 1 X 8'S(BATCH NO.: 240395, MFG. DT: 06/2024, EXP. DT: 05/2027) | $100.0K | 2 |
| DOXYCYCLINE 100MG CAPSULES 1 X 8'S(BATCH NO.: 240278, MFG. DT: 04/2024, EXP. DT: 03/2027) | $53.2K | 2 |
| Doxycycline 100mg Capsule [Total ExportQuantity = 3593200 Capsule Qty 71864x5x10] | $50.0K | 1 |
| DOXYCYCLINE 100MG CAPSULES 1 X 16S (BATCH NO. 240026, MFG. DT. 01/2024, EXP.DT. 12/2026) | $50.0K | 1 |
| DOXYCYCLINE 100MG CAPSULES 2 X 7'S(BATCH NO.: 240353, MFG. DT: 05/2024, EXP. DT: 04/2027) | $50.0K | 1 |
| DOXYCYCLINE 100MG CAPSULES 02 X 7S BATCH NO 230059A MFG DT 01 2023 EXP DT 12 2025 | $46.1K | 2 |
| DOXYCYCLINE 100MG CAPSULES 5 X 10S (BATCH NO. 240025, MFG. DT. 01/2024, EXP.DT. 12/2026) | $41.9K | 1 |
| Doxycycline 100mg Capsule [Total ExportQuantity =1616350 Capsule Qty 32327x5x10] | $41.2K | 1 |
| DOXYCYCLINE 100MG CAPSULES 01 X 8S (BAT | $41.0K | 1 |
| Doxycycline 100mg Capsule [Total ExportQuantity = 1440000 Capsule Qty 28800x5x10] | $38.4K | 1 |
DRUGSRUS LIMITED imports 37 distinct Doxycycline formulations from India. The top formulation is DOXYCYCLINE 100MG CAPSULES 1 X 8'S(BATCH NO.: 240395, MFG. D with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Doxycycline into United Kingdom
What DRUGSRUS LIMITED and other importers must comply with to import Doxycycline from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Doxycycline
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Doxycycline from India and How Much Does DRUGSRUS LIMITED Import?
India exported $23.7M worth of Doxycycline through 5,999 shipments from 408 suppliers to 149 countries, serving 1,051 buyers globally. DRUGSRUS LIMITED imports $765.4K of this total, accounting for 0.7% of India's Doxycycline exports with 41 shipments from UNITED KINGDOM. This is verified from 41 customs shipment records covering 37 distinct formulations.
What Is the Average Order Value for DRUGSRUS LIMITED's Doxycycline Imports?
DRUGSRUS LIMITED's average Doxycycline order value is $18.7K per consignment, based on 41 shipments totaling $765.4K. DRUGSRUS LIMITED is based in UNITED KINGDOM and ranks #15 among all Doxycycline importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Doxycycline to DRUGSRUS LIMITED?
DRUGSRUS LIMITED sources Doxycycline from 1 verified Indian supplier: PROSFORA TECHNOLOGIES PRIVATE LIMITED ($765.4K, 100.0%). This is based on 41 customs records.
How Does DRUGSRUS LIMITED Compare to Other Doxycycline Importers?
DRUGSRUS LIMITED ranks #15 among 1,051 Doxycycline importers from India with a 0.7% market share. The top 3 importers are AVET PHARMACEUTICALS INC ($6.3M), EVERSANA LIFE SCIENCE SERVICES ($3.3M), J. KNIPPER & COMPANY ($3.0M). DRUGSRUS LIMITED processed 41 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Doxycycline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Doxycycline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: DRUGSRUS LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as DRUGSRUS LIMITED's capped import value divided by total capped export value for Doxycycline across all Indian exporters.
- 5.Verified Records: This page is backed by 41 individual customs records matching DRUGSRUS LIMITED importing Doxycycline, covering 37 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,051+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Doxycycline Import Data for DRUGSRUS LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for DRUGSRUS LIMITED's Doxycycline imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DRUGSRUS LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
DRUGSRUS LIMITED × Doxycycline
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for DRUGSRUS LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Doxycycline. For current order-level data, contact TransData Nexus.